Skip to main content
. 2011 Apr;17(4):612–618. doi: 10.3201/eid1704.101480

Table 2. Antimicrobial drug susceptibility testing for Bordetella petrii isolates, by strain and strain type, October 2007–November 2008*.

Drug FR 3799, clinical† FR3891, clinical† FR 3996, clinical† FR 3497, clinical (17) KMRW, environmental (1) Fry et al., clinical (16)‡ Stark et al., clinical (18)
Penicillin >32 >32 >32 >32 >32 >32 ND
Amoxicillin >256 >256 >256 >256 8 >256 +clav: 4
Piperacillin 16 12 12 256 0.25 ND ND
Piperacillin and tazobactam 16 48 24 256 0.38 2 <4
Cefotaxime >32 >32 >32 >32 >32 >32 Ceftriax: >64
Ceftazidime 48 256 >256 2 4 32 16
Ertapenem >32 >32 >32 0.016 0.047 >32 ND
Imipenem 3 4 8 1 0.75 >32 ND
Meropenem 12 >32 12 0.023 0.047 >32 <0.25
Doripenem 32 >32 >32 0.094 0.125 ND ND
Gentamicin 1 1 1.5 12 3 4 4
Tobramycin 1 1 1 64 4 16 2
Amikacin 8 16 16 64 48 >256 8
Levofloxacin 16 24 24 2 0.25 ND ND
Ciprofloxacin >32 >32 >32 4 0.38 >32 2
Moxifloxacin 12 12 12 1.5 0.032 ND ND
Minocyclin 0.75 0.75 0.75 0.5 0.125 ND ND
Tygecyclin 0.75 1 1 0.25 0.023 ND ND
Cotrimoxazole 0.50 0.50 0.50 0.012 0.006 8 ND
Fosfomycin 4 8 8 6 12 ND ND
Quinupristin and dalfopristin >32 >32 >32 >32 >32 ND ND
Rifampin >32 >32 >32 >32 >32 >32 ND
Daptomycin >256 >256 >256 >256 >256 ND ND
Linezolid >256 >256 >256 >256 >256 ND ND
Clindamycin >256 >256 >256 >256 >256 >256 ND
Fucidic acid >256 >256 >256 >256 >256 ND ND

*Values are MICs by Etest in μg/mL. +clav, in combination with clavulanic acid; Ceftriax, ceftriaxone tested instead of cefotaxime; ND, not determined.
†This study.
‡Ampicillin was tested instead of amoxicillin.